Chang Sun to Biological Availability
This is a "connection" page, showing publications Chang Sun has written about Biological Availability.
Connection Strength
2.105
-
Relative Bioavailability Assessment of Solid Forms by An Artificial Stomach and Duodenum Apparatus. J Pharm Sci. 2024 08; 113(8):2506-2512.
Score: 0.820
-
Efficient development of sorafenib tablets with improved oral bioavailability enabled by coprecipitated amorphous solid dispersion. Int J Pharm. 2021 Dec 15; 610:121216.
Score: 0.686
-
Simultaneous improvement of physical stability, dissolution, bioavailability, and antithrombus efficacy of Aspirin and Ligustrazine through cocrystallization. Int J Pharm. 2022 Mar 25; 616:121541.
Score: 0.175
-
Novel Salt-Cocrystals of Berberine Hydrochloride with Aliphatic Dicarboxylic Acids: Odd-Even Alternation in Physicochemical Properties. Mol Pharm. 2021 04 05; 18(4):1758-1767.
Score: 0.164
-
Simultaneous taste-masking and oral bioavailability enhancement of Ligustrazine by forming sweet salts. Int J Pharm. 2020 Mar 15; 577:119089.
Score: 0.152
-
Expert insights into the development of large-volume subcutaneous drugs with permeation enhancers: A survey examining challenges, alternatives, and future directions. Int J Pharm. 2026 Jan 20; 689:126515.
Score: 0.057
-
Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p-Aminobenzoic acid. Int J Pharm. 2024 Mar 05; 652:123793.
Score: 0.050